[18F]fluoromethylcholine (FCH) positron emission tomography/computed tomography (PET/CT) for lymph node staging of prostate cancer: a prospective study of 210 patients. - Wikidata - awgldk - TriplyDB

[18F]fluoromethylcholine (FCH) positron emission tomography/computed tomography (PET/CT) for lymph node staging of prostate cancer: a prospective study of 210 patients.

[18F]fluoromethylcholine (FCH) positron emission tomography/computed tomography (PET/CT) for lymph node staging of prostate cancer: a prospective study of 210 patients.

http://www.wikidata.org/entity/Q38004182

about

Update on positron emission tomography for imaging of prostate cancer Nanoparticles as Theranostic Vehicles in Experimental and Clinical Applications-Focus on Prostate and Breast Cancer.Update on advances in molecular PET in urological oncology Consequence of the introduction of routine FCH PET/CT imaging for patients with prostate cancer: a dual centre survey.Role of (64)CuCl 2 PET/CT in staging of prostate cancer.EpCAM Expression in Lymph Node and Bone Metastases of Prostate Carcinoma: A Pilot Study.18F-Choline, 11C-choline and 11C-acetate PET/CT: comparative analysis for imaging prostate cancer patients.Choline PET/CT for imaging prostate cancer: an update.New acquisition protocol of 18F-choline PET/CT in prostate cancer patients: review of the literature about methodology and proposal of standardization Radiopharmaceuticals as probes to characterize tumour tissue.Initial prostate cancer diagnosis and disease staging--the role of choline-PET-CT.Imaging and evaluation of patients with high-risk prostate cancer.(68)Ga-PSMA-11 PET/CT: the rising star of nuclear medicine in prostate cancer imaging?PET imaging for lymph node dissection in prostate cancer.PET Tracers Beyond FDG in Prostate Cancer.PSMA PET and Radionuclide Therapy in Prostate Cancer.PET and PET/CT with radiolabeled choline in prostate cancer: a critical reappraisal of 20 years of clinical studies.Added value of cost-utility analysis in simple diagnostic studies of accuracy: (18)F-fluoromethylcholine PET/CT in prostate cancer staging.Laparoscopic extended pelvic lymph node (LN) dissection as validation of the performance of [(11) C]-acetate positron emission tomography/computer tomography in the detection of LN metastasis in intermediate- and high-risk prostate cancer.A fully-automated one-pot synthesis of [18F]fluoromethylcholine with reduced dimethylaminoethanol contamination via [18F]fluoromethyl tosylate.11C-Choline-Avid but 18F-FDG-Nonavid Prostate Cancer with Lymph Node Metastases on Positron Emission Tomography.Histological step sectioning of pelvic lymph nodes increases the number of identified lymph node metastases.Functional and Targeted Lymph Node Imaging in Prostate Cancer: Current Status and Future Challenges.The use of PET/CT in prostate cancer.Comparative effectiveness of [(18) F]-fluorocholine PET-CT and pelvic MRI with diffusion-weighted imaging for staging in patients with high-risk prostate cancer.Comparison of meta-analyses among elastosonography (ES) and positron emission tomography/computed tomography (PET/CT) imaging techniques in the application of prostate cancer diagnosis.Preoperative lymph node staging in patients with primary prostate cancer: comparison and correlation of quantitative imaging parameters in diffusion-weighted imaging and 11C-choline PET/CT.Spine metastases in prostate cancer: comparison of technetium-99m-MDP whole-body bone scintigraphy, [(18) F]choline positron emission tomography(PET)/computed tomography (CT) and [(18) F]NaF PET/CT.Prospective comparison of computed tomography, diffusion-weighted magnetic resonance imaging and [11C]choline positron emission tomography/computed tomography for preoperative lymph node staging in prostate cancer patients.MRI and 11C Acetate PET/CT for Prediction of Regional Lymph Node Metastasis in Newly Diagnosed Prostate Cancer.Tiny Obturator Node Metastasis from Prostate Cancer Not Shown by FDG-PET/CT, CT, or MRI Detected by 11C-Choline PET/CT.Discordance rate between radiolabelled choline PET/CT and bone scintigraphy in detecting bone metastases in patients with prostate cancer: a meta-analysis

P2860

Q27026828-58BDBBEF-8737-4B8E-9A43-D6CD8ADDF01F Q30354652-FB4A47DD-AE2C-4361-BC9F-F4973F0A0CA6 Q33625389-8E4E46C2-CA58-4001-A0FA-EADA3049F82A Q34040036-3FC7DDB5-8865-42D4-99C5-3EEF872AFF74 Q34469877-561ED318-2C6D-4390-B6AB-B7E7DA5C68CF Q37377297-9611C378-29CA-4A76-912E-58204F8C5458 Q38098441-344846E6-A559-449E-9A15-7A59036046B4 Q38103180-93C27F66-89C6-4174-B1C5-B008F9D378BF Q38239699-DDEEA9C6-4DD1-49B1-98ED-C7600297D1BB Q38342458-758E8D1A-FCB4-496B-8943-2B3575353766 Q38564109-41F7984E-03ED-4323-8945-1DB773169C32 Q38611187-B8DAD0E9-8813-480B-8722-9460921D7294 Q38747415-57490D61-32AB-464A-9673-AF8B1DBA68E4 Q38983526-697BB8A9-6227-44C0-A3E3-06907BEFA734 Q39003086-3519F2CB-5BC7-45FC-84D3-140904238F29 Q39003089-8E940822-BC47-424D-BAA8-650F442B71EF Q39242140-BEA732D0-22F1-401E-86A3-E50A046DBDAC Q39607551-B1398847-5A82-489E-BE4A-171B20CBAA35 Q40835837-B12FCA2F-BA4F-4526-9BE3-713B0810034C Q41840589-44E32236-50C7-4533-948F-52529D285D75 Q42362421-0AEC1A93-FEF1-468D-BC72-B84AD081DA21 Q43546775-495BC902-83C1-43F6-8694-C1884B7996A7 Q47829959-E4004DBD-9598-411A-AB57-DAB1BF3A3E78 Q49919217-824705E5-F7A7-4A15-9CE8-B26ACD7F266F Q50613922-AFF3B160-066D-4E42-B1E8-9FD43FFE600E Q52990619-62B8F3EE-67F5-4F40-A716-56A7478D0479 Q53064017-CAC721F8-0DAF-4DAF-8C46-0DB9A89A52C1 Q53086475-BA241A48-80BC-4B8D-9A9C-D1495EE5754C Q54501555-C1A5C87F-D5BE-4D6A-916A-0C22C2C8DE15 Q55000240-881CE3D6-2F9A-4023-88B9-DF934D8E18AE Q55405488-4459032D-743F-4A08-A0E1-3D6DCBD9F44D Q58005202-763ED288-BCF6-4227-9C7D-4F2BA2197303

P2860

[18F]fluoromethylcholine (FCH) positron emission tomography/computed tomography (PET/CT) for lymph node staging of prostate cancer: a prospective study of 210 patients.

http://www.wikidata.org/entity/Q38004182

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

[18F]fluoromethylcholine (FCH) ...... pective study of 210 patients.

@en

type

label

[18F]fluoromethylcholine (FCH) ...... pective study of 210 patients.

@en

prefLabel

[18F]fluoromethylcholine (FCH) ...... pective study of 210 patients.

@en

P1433

Q38004182-9156BCD2-3C77-4E66-80C7-2EC083157212

P1476

Q38004182-5B30B9A4-D9EE-4127-AE21-6ABA67F83C00

P2093

Q38004182-2B31A376-8F05-4592-ACF0-CA26F9FC5A06

Q38004182-31BC5CC5-A106-42E9-9318-2B86AC8D6A22

Q38004182-5E02FCE8-B983-4FAA-8DFF-60E1321E9F92

Q38004182-6A428F11-A127-41F1-B4E5-6BA817375425

Q38004182-7D945361-A302-4C18-BC42-4D9BDDFFC69B

Q38004182-B7E257A3-91E5-450A-B406-0F8AAF5E8F31

Q38004182-C8D9A114-4587-45C9-AAB9-3AE120289F3E

P2860

Q38004182-1547613A-B81A-4C1F-BEF7-09F4435C1B72

Q38004182-28A5A6B5-21B6-4E40-8053-BF6442576386

Q38004182-28F72152-82E1-4CC9-966C-0F6D8C2C0023

Q38004182-36D438FD-9FC8-4B23-B21D-BF75DCDBFC48

Q38004182-407FCAE5-3AA8-421A-8E9F-77BD8274A061

Q38004182-48D721E5-B9E8-4D5A-9C81-0D216D2CA234

Q38004182-55530A94-D922-4B97-BFAE-0D8C3CD5EAED

Q38004182-5AE8DA0C-5999-4C69-BFF1-719B908A759A

Q38004182-7726E45D-302B-46EC-BEE7-68FE22CFD17F

Q38004182-99E9ADD8-C2F3-4D97-997B-98802621A4BD

P304

Q38004182-969CF19B-E33C-4F40-9855-44D124DFE91B

P31

Q38004182-BD2A426B-2A1F-4B3B-AFA3-FC7991370646

P356

Q38004182-E524EB2A-060E-4209-B9FD-D7FAC4D71F69

P433

Q38004182-6C7668F8-0F67-4C7D-BE31-1B783DF6C151

P478

Q38004182-FB632E6F-2329-44F1-9167-E5D93C01D906

P50

Q38004182-17CA042D-D52F-45B5-B438-C087C0AEE7BD

Q38004182-2625462C-0600-42CD-B999-B549C4C25CE5

Q38004182-3016927C-EE2B-46F5-89AF-DA2344BAD17F

Q38004182-77E7FF86-2661-454C-8752-F1CAE36B2B45

P577

Q38004182-3649D5EF-C32F-46C8-A9A3-0B424609661E

P698

Q38004182-423A583C-F736-4BA9-969A-6FE1D774E28B

P921

Q38004182-9F74E0D0-8F86-41A0-ACFC-D73CF3D1267F

P356

J.1464-410X.2012.11150.X

P1433

BJU International

P1476

[18F]fluoromethylcholine (FCH) ...... spective study of 210 patients

@en

P2093

Kirsten Bouchelouche

http://www.w3.org/2001/XMLSchema#string

Niels Marcussen

http://www.w3.org/2001/XMLSchema#string

Niels Svolgaard

http://www.w3.org/2001/XMLSchema#string

Poul F Høilund-Carlsen

http://www.w3.org/2001/XMLSchema#string

Signe Inglev Steffansen

http://www.w3.org/2001/XMLSchema#string

Steen Walter

http://www.w3.org/2001/XMLSchema#string

Ulla Geertsen

http://www.w3.org/2001/XMLSchema#string

P2860

Management of recurrent disease after radical prostatectomy.

Imaging prostate cancer: an update on positron emission tomography and magnetic resonance imaging

An analysis of radical prostatectomy in advanced stage and high-grade prostate cancer.

The diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer: a meta-analysis.

Pelvic lymph node dissection in prostate cancer.

Positron emission tomography/computed tomography and radioimmunotherapy of prostate cancer.

PET/CT for the staging and follow-up of patients with malignancies.

18F choline PET/CT in the preoperative staging of prostate cancer in patients with intermediate or high risk of extracapsular disease: a prospective study of 130 patients.

EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease.

Biodisposition and metabolism of [(18)F]fluorocholine in 9L glioma cells and 9L glioma-bearing fisher rats.

P304

1666-1671

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1464-410X.2012.11150.X

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

110

http://www.w3.org/2001/XMLSchema#string

P50

Henrik Petersen

P577

2012-04-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22520686

http://www.w3.org/2001/XMLSchema#string

P921